Immunotherapy drugĀ approved for head and neck cancer
Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.
Oct 27, 2020
0
3
Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.
Oct 27, 2020
0
3
Care homes in England experienced the highest increase in excess deaths at the height of the COVID-19 pandemic compared to those in the rest of the UK, according to new research.
Aug 31, 2020
0
3
Over 1,000 children from Northern Ireland, Scotland, England and Wales, known as "COVID Warriors" have had their antibodies measured in the UK-wide trial called "Seroprevalence of SARS-Cov-2 infection in healthy children."
Aug 28, 2020
0
7
The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukemia (AML) on the NHS in England. The National Institute for Health and Care Excellence (NICE) overturned their initial rejection of ...
Jul 17, 2020
0
2
The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin to treat some adults with a rare type of fast-growing lymphoma.
Jul 13, 2020
0
3
The siblings of infants who have died suddenly and unexpectedly run 10 times the risk of dying in the same way, indicates a long term analysis of monitoring data, published online in the Archives of Disease in Childhood.
Jun 11, 2020
0
3
Household factors such as access to outdoor space, overcrowding as well as financial and employment precarities make some households significantly more vulnerable to the effects of COVID-19, according to a new study carried ...
May 5, 2020
0
1
The U.K. could have zero new cases as early as 10th May, but no later than the end of May, new research conducted by the University of Warwick suggests.
Apr 10, 2020
0
2
Ireland on Saturday confirmed its first case of coronavirus after a man who had returned from northern Italy tested positive, the government said.
Feb 29, 2020
0
8
Adults in England with advanced lung cancer will not have access to a new targeted cancer drug, lorlatinib (Lorviqua).
Feb 5, 2020
0
1